Health care stocks were mixed Thursday afternoon, with the NYSE Health Care Index rising 0.3% and the Health Care Select Sector SPDR Fund (XLV) fractionally lower.
The iShares Biotechnology ETF (IBB) fell 1.1%.
In corporate news, Aspire Biopharma (ASBP) shares rose 2.3% after it said Thursday its contract manufacturer Glatt Air Techniques produced the first clinical batch of pharmaceutical-grade oral mucosal form of aspirin with Aspire's formulation ahead of a bioavailability study expected to begin in April.
OptiNose (OPTN) shares surged 52% after the company overnight said it agreed to be acquired by Paratek Pharmaceuticals in a deal valued at up to $330 million.
Aptevo Therapeutics (APVO) shares added 1.1% after it said Thursday that two additional acute myeloid leukemia patients achieved remission within 30 days of treatment in a trial evaluating mipletamig with standard therapy for patients unfit for intensive chemotherapy.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。